A. P. Menchon-jm and P. J. Mataix-cols, Long term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy

A. Gw, Orthostatic hypotension induced by sertraline withdrawal, Pharmacotherapy, issue.4, pp.16-684, 1996.

A. Dk, Withdrawal after discontinuation syndrome of paroxetine

B. L. Le and H. Fc, Paroxetine withdrawal syndrome, Ann Med Interne, vol.151, pp.52-55, 2000.

B. R. , R. V. Vindran, and . Chaput-y, Sertraline and fluoxetine treatrnent of OCD : results of a double-blind, 6-months treatment study

B. Cs, Fluoxetine withdrawal symptoms

B. Dw and . Wesner-r, The abrupt discontinuation of fluvoxamine in patients with panic disorder

B. K. and S. C. Dursun-s, Selective serotonin reuptake inhibitor discontinuation syndrome : proposed diagnostic criteria

B. M. Stager-sv, R. Braun-ar, and . Dr, Severe psychiatrie symptoms associated with paroxetine withdrawal, Lancet, pp.346-57, 1995.

B. F. Bellino-s, R. Rb, and P. L. , Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation

C. Hk, . Lennard-ms, . Tucker-gt, . Woods-fr, and . Haddock-re, The effect of serotonin re-uptake inhibitors on cytochrome P4502D6 activity in human liver microsomes

D. Ml and . Olhager-e, Paroxetine withdrawal syndrome in a neonate

D. C. Schatzberg-af, Physical Symptoms Associated with paroxetine withdrawal

D. V. Matteo, C. M. , D. Giulio, and C. Esposito-e, Role of serotonin(2C)receptors in the control ofbrain dopaminergic fonction

D. Ver-sc, G. Jf, and S. Rm, Antidepressant withdrawal syndromes : phenomenology and pathophysiology

D. Rogoz-z, S. G. , D. D. , and M. J. , Effect ofrepeated treatment with tianeptine and fluoxetine on central dopamine D2

F. Ga and G. S. , Withdrawal syndromes after paroxetine and sertraline discontinuation

G. C. and W. H. Haddad-p, SSRis and withdrawal syndrome, Proceedings of the lOth world congress of Psychiatry, 1996.

G. Ml and H. Grinspoon-l, Ritualistic use of fluoxetine by a former substance abuser

H. Pm and . Qureshi-m, Misdiagnosis of antidepressant discontinuation symptoms

H. Pm, Antidepressant discontinuation syndromes, Drug Saf, vol.24, issue.3, pp.183-97, 2001.

H. I. , K. S. , and C. Sm, Abrupt and brief discontinuation of antidepressant treatment : effects on cognitive fonction and psychomotor performance

J. E. Gaillac-v and G. Jd, Serotonin syndrome. Which treatment and when?

K. Db, . Huang-fy, and . Da, Comorbidity between patterns of substance use dependence and psychiatrie syndromes

K. Nj, C. P. , R. J. , M. We, B. Ml et al., Medication withdrawal symptoms in obsessive-compulsive disorder patients treated with paroxetine

K. Gf, Neurochemical explanations for addiction. Hospital practice. A special report : New understanding of drug addiction Mac GrawHill, pp.12-15, 1997.

K. Lm, R. Hackett-e, and W. R. Robinson-d, Efficacity of sertraline in the long-term treatment of OCD

L. A. and L. Gm, Potential withdrawal syndrome associated with SSRI discontinuation

L. Fl, . Nierenberg-aa, S. Sanders-km, and . Ta, Discontinuation reactions following sertraline

L. Moal-m, Neurobiologie de la dépendance, Rev Prat, vol.45, pp.1351-1359, 1995.

L. Ak, A. Lannon-ra, and . Lj, Withdrawal reaction after sertraline discontinuation

M. S. Taylor-d, Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression

M. Js, . Dev-ane-cl, M. Liston-hl, and . Sa, An assessment of selective serotonin reuptake inhibitor discontinuation symptoms with Citalopram, pp.329-333, 2000.

M. P. Menecier-ossia and . Bern-p, Fluoxetine dependence and tolerance. A propos of a case

M. D. Fa, A. J. Apter-j, . Londborg-p, . Tamura-r, and . Tepner-rg, Interruption of selective serotonin reuptake inhibitor treatment. Double blind

M. Jl, . Senard-jm, and . Lapeyre-mestre-m, A propos des antidépresseurs : quelques réflexions pharmacologiques

N. Ej and A. Gk, Molecular and cellular basis of addiction, Science, vol.278, pp.58-62, 1997.

N. H. Lindermann-r and . Perminov-kv, REIKV AM A Neonatal withdrawal syndrome after in utero exposure to selective reuptake inhibitors

N. Dj, Addiction : brain mechanisms and their treatment implications, Lancet, vol.437, pp.31-37, 1996.

O. S. , C. Pb, and . Behnke-k, Paroxetine in the treatment of panic disorders : a randomized double blind, placebo-controlled study

O. Jp, . Poirier-mf, and . Loo-h, Les maladies dépressives, Médecine sciences Flammarion, pp.3-10

R. Jf, Clinical management of antidepressant discontinuation

R. Jf, H. M. Fa, and . Sl, Selective serotonin reuptake inhibitor discontinuation syndrome : a randomized clinical trial

R. Ha, Sertraline withdrawal in two brothers: a case report

S. Af, Antidepressant discontinuation syndrome: an update on serotonin reuptake inhibitors

S. Af, . Haddad-p, E. Kaplan, . Lejoyeux-m, Y. Rosenbaum-jf et al., Possible biological mechanisms of serotonin reuptake inhibitor discontinuation syndrome

S. M. Antidépresseurs, In : Phannacologie, 3ème édition

S. Sh and K. Mg, Introduction to the special issue on "anxiety sensitivity and addictive behaviours

T. E. Hisa-wa-s, Clinically significant pharmacokinetic drug interactions with psychoactive drugs: antidepressant and antipychotics and cytochrome P450 system

T. Jp, Drogues, dependances et dopamine, La recherche, vol.306, pp.48-53, 1998.

T. F. and M. Js, Selective serotonin reuptake inhibitors and withdrawal symptoms : A review of the literature

Y. A. Currie-a, Physician's knowledge of antidepressant withdrawal eff ects : a survey

Z. J. and T. K. Mitchell-s, Discontinuation symptoms after treatment with serotonin reuptake inhibitors : a literature review

Z. J. , F. J. , A. J. , Q. F. , R. F. et al., Safety of abrupt discontinuation of fluoxetine: a randomized

K. S. Gallowa and . Mp, MDMA induced dopamine release in vivo: role of endogenous serotonin

M. Dt and T. Da, Modulation by fluoxetine of striatal dopamine release following Delta9-tetrahydrocannabinol: a microdialysis study in conscious rats

R. T. Yer, Effects of changes in brain 5-HT activity on indicators of cortical arousal